Silver Sponsor and exhibitor, Modality Solutions, joins a “who’s who” of pharmaceutical decision makers at the Executive Platform’s Biomanufacturing World Summit (BMWS18) in San Diego on October 29-30.
The BMWS18 brings together pharmaceutical executives, cutting-edge technology providers and media partners for its North America premier biologics event. President Gary Hutchinson and Principal Daniel Littlefield will attend the conference and participate in one-to-one meetings with other leaders in biopharmaceutical manufacturing and cold chain management.
BMWS18 participants learn about and discuss:
• Industry challenges and opportunities
• Quality as a culture, QbD, ICH guidelines
• Capacity management
• Supply chain management
• New processes and technologies
• Working with external partner
Modality Solutions is committed to helping biopharmaceutical companies explore cost-reduction strategies, understand changing industry standards, and initiate risk management processes to ensure compliance, quality and product integrity.
Click here to view the Modality Solutions BMWS18 press release.
Today, four leading life science companies—Suttons Creek, Modality Solutions, CLINTREX, and ToxStrategies—announce their unification...
read Details
Modality Solutions is proud to announce the launch of our new Greenwood Lab—a state-of-the-art...
read Details
Congratulations to Vertex for their UK approval for CASGEVY™, a CRISPR/Cas9 gene-edited therapy, for...
read Details
